Your session is about to expire
← Back to Search
Antidepressant
Bupropion XL for Depression
Phase 4
Waitlist Available
Led By Andrew Miller, MD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 2, week 4, week 6, week 8
Awards & highlights
Study Summary
This trial will test whether bupropion can help people with depression and increased inflammation who also have problems with anhedonia.
Eligible Conditions
- Depression
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, week 2, week 4, week 6, week 8
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 2, week 4, week 6, week 8
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Targeted Ventromedial Prefrontal Cortex-Ventral Striatal (vmPFC-VS) Functional Connectivity (FC)
Secondary outcome measures
Inventory of Depressive Symptomatology - Self-Report (IDS-SR)
Motivation and Pleasure Scale-Self-Report (MAP-SR) Score
Proportion of Hard-Task Choices During the Effort-Expenditure for Rewards Task (EEfRT)
+1 moreSide effects data
From 2022 Phase 4 trial • 18 Patients • NCT0435210120%
Itching
20%
Nausea
20%
Anxious mood
10%
Insomnia
10%
Dry mouth
10%
Vivid dreams
10%
Pain in limb
10%
Nocturnal perspiration
10%
Lightheadedness
10%
Headache
10%
Stress
10%
Chest pain
10%
High blood pressure
10%
Enlarged lymph nodes
100%
80%
60%
40%
20%
0%
Study treatment Arm
Bupropion
Escitalopram
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: BupropionExperimental Treatment1 Intervention
Participants randomized to take bupropion for 8 weeks.
Group II: EscitalopramActive Control1 Intervention
Participants randomized to take escitalopram for 8 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupropion XL
2009
Completed Phase 4
~370
Find a Location
Who is running the clinical trial?
Emory UniversityLead Sponsor
1,646 Previous Clinical Trials
2,564,582 Total Patients Enrolled
59 Trials studying Depression
8,998 Patients Enrolled for Depression
National Institute of Mental Health (NIMH)NIH
2,798 Previous Clinical Trials
2,660,900 Total Patients Enrolled
672 Trials studying Depression
253,325 Patients Enrolled for Depression
Andrew Miller, MDPrincipal InvestigatorEmory University
2 Previous Clinical Trials
374 Total Patients Enrolled
1 Trials studying Depression
20 Patients Enrolled for Depression
Share this study with friends
Copy Link
Messenger